Abbott Laboratories
Statements
Cash Flow
Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 2,488 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,217 | 1,170 | 574 | 1,351 | 2,005 | 1,640 | 1,108 | 1,244 | 2,183 | 1,765 | 712 | 1,060 | 1,948 | 2,416 | 715 | 1,322 | 2,066 | 3,798 | 2,637 | 2,128 | 2,701 | 3,067 | 2,065 | 2,410 | 2,780 | 2,326 | 1,143 | 1,203 | 1,877 | 3,038 | 1,025 | 1,960 | 2,705 | 2,868 | 1,417 | 2,047 | 2,787 | 3,315 | 1,315 | 2,488 | 9,905 | |
| 340 | 319 | 774 | 648 | 756 | 843 | 852 | 850 | 813 | 763 | 753 | 751 | 754 | 756 | 828 | 825 | 808 | 866 | 934 | 874 | 847 | 883 | 823 | 822 | 815 | 807 | 806 | 800 | 824 | 813 | 805 | 805 | 801 | 807 | 756 | 777 | 791 | 792 | 730 | 1,013 | 3,326 | |
| 49 | 47 | 171 | 92 | 75 | 68 | 212 | 101 | 83 | 81 | 226 | 114 | 94 | 85 | 233 | 115 | 100 | 98 | 288 | 132 | 114 | 106 | 305 | 142 | 123 | 115 | 281 | 132 | 117 | 114 | 304 | 141 | 117 | 111 | 289 | 142 | 120 | 113 | 317 | 168 | 718 | |
| 1,000 | 46 | -980 | 92 | 63 | 23 | 212 | 101 | 83 | 248 | 226 | 114 | 94 | 332 | 233 | 115 | 100 | 98 | 288 | 132 | 114 | 106 | 305 | 142 | 123 | 115 | 281 | 132 | 117 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 31 | -1,245 | -132 | -51 | 53 | 2,045 | -224 | -249 | -257 | 582 | -456 | -419 | -212 | -244 | -541 | -319 | -321 | 289 | -372 | -67 | -360 | -106 | -1,510 | -572 | 336 | 114 | -186 | -444 | -2,866 | -1,524 | -561 | -428 | 163 | -8,391 | -953 | -651 | 232 | 569 | -882 | 734 | 653 | |
| 312 | 319 | 272 | 255 | 263 | 345 | 275 | 298 | 354 | 467 | 335 | 468 | 401 | 434 | 360 | 642 | 496 | 679 | 397 | 413 | 461 | 614 | 321 | 379 | 467 | 610 | 380 | 507 | 560 | 755 | 398 | 533 | 556 | 720 | 484 | 502 | 496 | 689 | 399 | 399 | 1,983 | |
| -554 | 1,550 | -6,154 | -6.0 | -306 | -3,152 | -238 | -299 | -323 | -496 | -396 | -498 | -432 | -489 | -393 | -619 | -472 | -731 | -422 | -264 | -651 | -671 | -360 | -264 | -484 | -632 | -462 | -1,213 | -634 | -824 | -425 | -453 | -594 | -866 | -470 | -582 | -457 | -913 | -20,324 | -673 | -22,367 | |
| 384 | 386 | 460 | 462 | 463 | 464 | 491 | 494 | 494 | 495 | 565 | 568 | 569 | 568 | 638 | 642 | 639 | 641 | 800 | 803 | 801 | 798 | 832 | 828 | 826 | 823 | 890 | 890 | 888 | 888 | 957 | 961 | 960 | 958 | 1,026 | 1,029 | 1,031 | 1,030 | 1,098 | 1,102 | 4,261 | |
| -2.0 | 42 | -95 | -3.0 | -8.0 | -721 | -128 | -3.0 | -3.0 | -104 | -217 | -4.0 | -1.0 | -496 | -236 | -4.0 | -2.0 | -161 | -275 | -471 | -579 | -974 | -2,307 | -5.0 | -798 | -685 | -540 | -426 | -835 | -259 | -226 | -3.0 | -751 | -315 | -280 | -6.0 | -305 | -302 | -180 | -1,045 | -1,832 | |
| -398 | 13,848 | -3,960 | 24 | -4.0 | 998 | -5,973 | -1,167 | 2,894 | -4,204 | -487 | 6.0 | 10 | -1,128 | 50 | 1,258 | -1,357 | -1.0 | 22 | -7.0 | -67 | -196 | -743 | 10 | 24 | 756 | -42 | 12 | -1,506 | – | – | – | 43 | -613 | -1,036 | -15 | -493 | -70 | 18,475 | – | – | |
| -746 | 13,504 | -4,399 | -384 | -386 | -112 | -6,455 | -1,631 | 2,471 | -4,776 | -1,142 | -449 | -513 | -2,185 | -735 | 658 | -1,915 | -787 | -967 | -1,264 | -1,377 | -1,886 | -3,823 | -813 | -1,543 | -1,457 | -1,410 | -1,289 | -2,340 | -2,052 | -1,176 | -791 | -1,576 | -1,861 | -2,055 | -1,097 | -1,760 | -1,397 | 17,313 | -3,518 | 10,638 | |
| -78 | 16,120 | -9,914 | 969 | 1,337 | -1,605 | -5,550 | -792 | 4,304 | -3,525 | -822 | 115 | 954 | -231 | -483 | 1,386 | -283 | 2,358 | 1,216 | 604 | 644 | 497 | -2,124 | 1,262 | 657 | 288 | -721 | -1,326 | -1,126 | 187 | -612 | 703 | 571 | 58 | -1,084 | 419 | 560 | 1,011 | -1,719 | -1,699 | -1,847 | |
| 905 | 851 | 302 | 1,096 | 1,742 | 1,295 | 833 | 946 | 1,829 | 1,298 | 377 | 592 | 1,547 | 1,982 | 355 | 680 | 1,570 | 3,119 | 2,240 | 1,715 | 2,240 | 2,453 | 1,744 | 2,031 | 2,313 | 1,716 | 763 | 696 | 1,317 | 2,283 | 627 | 1,427 | 2,149 | 2,148 | 933 | 1,545 | 2,291 | 2,626 | 916 | 2,887 | 8,720 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.